May 20, 2020 / 04:00PM GMT
Randall S. Stanicky - RBC Capital Markets, Research Division - MD of Global Equity Research & Lead Analyst
Okay. Great. Thanks, everybody, for joining us for day -- our day 2 keynote event. I'm Randall Stanicky, a Pharmaceuticals Analyst here at RBC Capital Markets and joined by my colleague Alex Zukin, who covers the software industry as well as Microsoft.
And just to say, I mean, we're both really excited to have our next keynote speaker with us, Dr. Greg Moore. He's the Corporate Vice President of Microsoft Health, responsible for a host of initiatives, from product strategy to product development, research, including AI, machine learning technology for the life sciences. So a lot of responsibility there. He's also Microsoft's senior executive leading the dedicated R&D collaborations with the company's strategic partners. And that's going to be something that we talk about as well.
And just to give a bit of a background here because it's actually quite important. When you look at his interdisciplinary background, I mean, I think it helps explain how complex and, really, the
Microsoft Corp at RBC Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
